FR2389136A1 - Procede de dosage global d'hormones et de produits pharmaceutiques - Google Patents

Procede de dosage global d'hormones et de produits pharmaceutiques

Info

Publication number
FR2389136A1
FR2389136A1 FR7812342A FR7812342A FR2389136A1 FR 2389136 A1 FR2389136 A1 FR 2389136A1 FR 7812342 A FR7812342 A FR 7812342A FR 7812342 A FR7812342 A FR 7812342A FR 2389136 A1 FR2389136 A1 FR 2389136A1
Authority
FR
France
Prior art keywords
hormones
pharmaceutical products
global
pharmaceuticals
dosage process
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
FR7812342A
Other languages
English (en)
Other versions
FR2389136B1 (fr
Inventor
Hans A Dr Thoma
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Chandon Investment Planning Ltd
Original Assignee
Chandon Investment Planning Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chandon Investment Planning Ltd filed Critical Chandon Investment Planning Ltd
Publication of FR2389136A1 publication Critical patent/FR2389136A1/fr
Application granted granted Critical
Publication of FR2389136B1 publication Critical patent/FR2389136B1/fr
Granted legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/74—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving hormones or other non-cytokine intercellular protein regulatory factors such as growth factors, including receptors to hormones and growth factors
    • G01N33/743—Steroid hormones
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00—Chemistry: analytical and immunological testing
    • Y10S436/804—Radioisotope, e.g. radioimmunoassay
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00—Chemistry: analytical and immunological testing
    • Y10S436/815—Test for named compound or class of compounds
    • Y10S436/817—Steroids or hormones
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00—Chemistry: analytical and immunological testing
    • Y10S436/825—Pretreatment for removal of interfering factors from sample

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • Food Science & Technology (AREA)
  • Endocrinology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Peptides Or Proteins (AREA)
  • Immobilizing And Processing Of Enzymes And Microorganisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Addition Polymer Or Copolymer, Post-Treatments, Or Chemical Modifications (AREA)

Abstract

Procédé de dosage global d'hormones ou de produits pharmaceutiques partiellement liés à des protéines de liaison spécifiques ou non-spécifiques par hydrolyse enzymatique des protéines de liaison, réaction des hormones ou produits pharmaceutiques avec un anticorps et dosage immunologique des hormones ou produits pharmaceutiques. Il consiste à utiliser des anticorps immobilisés. Ce procédé permet un dosage global des hormones et produits pharmaceutiques sans stage de dénaturation, ce qui lui confère des possibilités d'utilisation universelles, et facilite son automatisation.
FR7812342A 1977-04-27 1978-04-26 Procede de dosage global d'hormones et de produits pharmaceutiques Granted FR2389136A1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19772718700 DE2718700A1 (de) 1977-04-27 1977-04-27 Verfahren zur gesamtbestimmung von hormonen und pharmaka

Publications (2)

Publication Number Publication Date
FR2389136A1 true FR2389136A1 (fr) 1978-11-24
FR2389136B1 FR2389136B1 (fr) 1984-05-04

Family

ID=6007401

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7812342A Granted FR2389136A1 (fr) 1977-04-27 1978-04-26 Procede de dosage global d'hormones et de produits pharmaceutiques

Country Status (26)

Country Link
US (1) US4235866A (fr)
JP (1) JPS5417115A (fr)
AT (1) AT357691B (fr)
AU (1) AU518437B2 (fr)
BE (1) BE866488A (fr)
BR (1) BR7802597A (fr)
CA (1) CA1106758A (fr)
CH (1) CH640060A5 (fr)
CS (1) CS200547B2 (fr)
DD (1) DD136428A5 (fr)
DE (1) DE2718700A1 (fr)
DK (1) DK181278A (fr)
FI (1) FI781218A (fr)
FR (1) FR2389136A1 (fr)
GB (1) GB1603774A (fr)
GR (1) GR64472B (fr)
HU (1) HU177804B (fr)
IE (1) IE46807B1 (fr)
IL (1) IL54556A (fr)
LU (1) LU79536A1 (fr)
NL (1) NL7804464A (fr)
NO (1) NO781471L (fr)
NZ (1) NZ187069A (fr)
PL (1) PL110972B1 (fr)
SE (1) SE7804799L (fr)
ZA (1) ZA782360B (fr)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3168691D1 (en) * 1980-11-07 1985-03-14 Technicon Instr Immunoassay of proteins
US4452903A (en) * 1981-02-17 1984-06-05 Lee Jin P Assay method and reagent kit means for lipid-containing body fluid
US4393040A (en) * 1981-03-24 1983-07-12 Lopapa Institute, Inc. In-vitro diagnostic method for detection of acetylsalicylic acid ingestion
US4659655A (en) * 1981-11-25 1987-04-21 Bio-Response, Inc. Method for isolating product-producing cells
US4790919A (en) * 1984-06-28 1988-12-13 E. I. Du Pont De Nemours And Company Process for preparation of electrophoresis gel material
NZ217821A (en) * 1985-10-10 1989-07-27 Biotech Australia Pty Ltd Oral delivery system; complex of active agent and vitamin b12 or analogue thereof
US5807832A (en) * 1987-06-09 1998-09-15 Biotech Australia Pty Limited Oral delivery of biologically active substances bound to vitamin B12
JP2523171B2 (ja) * 1987-08-12 1996-08-07 帝人株式会社 免疫測定方法及びそれに用いる試薬キット
WO1992017167A1 (fr) * 1991-04-02 1992-10-15 Biotech Australia Pty. Ltd. Systemes de liberation orale de microparticules

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1054050A (fr) * 1973-05-01 1979-05-08 Stuart J. Updike Colonne de gel utilisee dans la purification de sang et les dosages immunologiques
US3925017A (en) * 1973-05-01 1975-12-09 Wisconsin Alumni Res Found Preparation of dry, porous gel particles having high water regain for liquid sampling
US3962039A (en) * 1974-08-08 1976-06-08 Center For Laboratory Medicine Analytical procedure for thyroid hormones
US4061466A (en) * 1974-10-16 1977-12-06 Ingvar Gosta Holger Sjoholm Biologically active composition and the use thereof
GB1524372A (en) * 1975-01-09 1978-09-13 Radiochemical Centre Ltd Radioassay of oestrogens

Also Published As

Publication number Publication date
LU79536A1 (de) 1978-09-29
SE7804799L (sv) 1978-10-28
GR64472B (en) 1980-03-27
CH640060A5 (de) 1983-12-15
BE866488A (fr) 1978-08-14
AT357691B (de) 1980-07-25
DE2718700A1 (de) 1978-11-02
CS200547B2 (en) 1980-09-15
JPS6217189B2 (fr) 1987-04-16
DK181278A (da) 1978-10-28
DD136428A5 (de) 1979-07-04
ZA782360B (en) 1979-04-25
US4235866A (en) 1980-11-25
BR7802597A (pt) 1978-12-19
PL206414A1 (pl) 1979-01-15
FR2389136B1 (fr) 1984-05-04
AU3536578A (en) 1979-10-25
IE780833L (en) 1978-10-27
ATA290778A (de) 1979-12-15
CA1106758A (fr) 1981-08-11
NL7804464A (nl) 1978-10-31
JPS5417115A (en) 1979-02-08
IL54556A0 (en) 1978-07-31
NZ187069A (en) 1980-12-19
HU177804B (en) 1981-12-28
PL110972B1 (en) 1980-08-30
IE46807B1 (en) 1983-09-21
NO781471L (no) 1978-10-30
IL54556A (en) 1983-03-31
GB1603774A (en) 1981-11-25
AU518437B2 (en) 1981-10-01
FI781218A (fi) 1978-10-28

Similar Documents

Publication Publication Date Title
ES8303702A1 (es) "un procedimiento para preparar un vehiculo artificial util para el material de un reactivo de diagnostico".
FR2373063A1 (fr) Procede de dosage avec fixation specifique, en utilisant un modulateur d'enzyme comme substance de marquage
NL7804015A (nl) Werkwijze voor het bereiden van een proteineconcentraat dat van melkzuur afkomstige immunologische faktoren be- vat, alsmede als zodanig verkregen produkt.
FR2389136A1 (fr) Procede de dosage global d'hormones et de produits pharmaceutiques
ATE414171T1 (de) Verfahren zur immobilisierung von oligonukleotiden auf festem trägermaterial
GB1348935A (en) Process for the determination of low molecular compounds and of proteins capable of binding these compounds specifically
SE8800864D0 (sv) Method of assaying of nucleic acids, a reagent combination and kit therefore
NL7610984A (nl) Werkwijze voor het bestuderen van enzymatische andere biochemische reacties.
DK242781A (da) Assaymetode og reagens dertil
JPS55108815A (en) Active substance dropping medicine and its manufacture
NL7904308A (nl) Werkwijze en reagens voor bioluminescentiereacties.
SE8003732L (sv) Sett vid bestemningsmetoder involverande biospecifika affinitetsreaktioner
ATE4126T1 (de) Verfahren und reagenz zur enzymatischen bestimmung von enzymsubstraten.
ES8703201A1 (es) Un metodo para determinar una secuencia particular de poli- nucleotidos en un medio de ensayo que contiene acidos nu- cleicos monocatenarios
DD136187A5 (de) Mehrkanalsystem zur handhabung von immobilisierten biologisch-aktiven substanzen
FR2413400A1 (fr) Produits biochimiques insolubilises et stabilises et leur application en tant que reactifs immunochimiques
FR2396975A1 (fr) Procede de dosage d'hormones ou de produits pharmaceutiques non lies
DE3650432D1 (de) Verfahren und Verwendung für ortspezifische Aktivierung von Substanzen.
NL190744C (nl) Werkwijze voor de bereiding van een vaste, stabiele, gemakkelijk hanteerbare samenstelling op basis van lysine, geschikt als diervoeder, alsmede een dergelijke samenstelling.
ATE141290T1 (de) M-csf-monoklonale antikörper, die ein neutralisierendes konformationales epitop erkennen
DK600988D0 (da) Fremgangsmaade til forarbejdning af animalske ekskrementer, et ved fremgangsmaaden opnaaet vaerdifuldt goedskningsmiddel samt dets anvendelse
DE3683101D1 (de) Mit ueberzuegen versehene formkoerper zur bindung von bioaffinen substanzen.
BR7507475A (pt) Veiculo para medicao imuno-quimica,processo de sua preparacao,sistema de reacao para a medicao imuno-quimica e processo para medicao imuno-quimica de componentes biologicos
ES2071610T3 (es) Proteina l y sus subfragmentos, con actividad de union a inmunoglobulinas, un procedimiento para su preparacion, estuche de reactivos, composicion farmaceutica y una cepa de peptococcus magnus.
ES8206038A1 (es) Sistema fisico-bioquimico para la deteccion de sustancias deactividad antigenica.

Legal Events

Date Code Title Description
ST Notification of lapse